Baclofen prevented loss of GABABR2 expression after ALI and significantly inhibited release of pro-inflammatory modulators TNF-α and Interleukin-1 receptor accessory protein (IL-1R AcP), while concurrently promoting BAL neutrophil apoptosis. The gene discussed is GABBR2; the disease is acute respiratory distress syndrome.